H.C. Wainwright Starts Aerie Pharma (AERI) at Buy

September 20, 2016 8:41 AM EDT Send to a Friend
H.C. Wainwright initiated coverage on Aerie Pharma (NASDAQ: AERI) with a Buy rating and a price target of $66. Analyst ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login